Vertex Announces Expanded Reimbursement Agreement With NHS England
Agreement Includes a Fourth Cystic Fibrosis Medicine, Pending Approval
Data for Investigational Gene-Editing Program Highlighted at Virtual EHA
Vertex and CRISPR Therapeutics share new clinical data for severe hemoglobinopathies and highlight clinical program progress at 25th European Hematology Association Congress
2019 Corporate Responsibility Report
Learn about our corporate responsibility priorities and progress
Check Out Our 360-Degree Virtual Lab Experience
Grab your lab coat and goggles to see Vertex's state of the art laboratory in San Diego
Featured contents
We Are Vertex